K

Kilitch Drugs (India) Ltd
NSE:KILITCH

Watchlist Manager
Kilitch Drugs (India) Ltd
NSE:KILITCH
Watchlist
Price: 323.15 INR -0.46%
Market Cap: 5.2B INR
Have any thoughts about
Kilitch Drugs (India) Ltd?
Write Note

Kilitch Drugs (India) Ltd
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kilitch Drugs (India) Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
K
Kilitch Drugs (India) Ltd
NSE:KILITCH
EPS (Diluted)
â‚ą10
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
EPS (Diluted)
â‚ą64
CAGR 3-Years
-18%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
EPS (Diluted)
â‚ą55
CAGR 3-Years
20%
CAGR 5-Years
22%
CAGR 10-Years
15%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
EPS (Diluted)
â‚ą46
CAGR 3-Years
21%
CAGR 5-Years
21%
CAGR 10-Years
4%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
EPS (Diluted)
â‚ą53
CAGR 3-Years
12%
CAGR 5-Years
26%
CAGR 10-Years
8%
M
Mankind Pharma Ltd
NSE:MANKIND
EPS (Diluted)
â‚ą47
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Kilitch Drugs (India) Ltd
Glance View

Market Cap
5.2B INR
Industry
Pharmaceuticals

Kilitch Drugs (India) Ltd. engages in the manufacture and sale of pharmaceuticals, medicinal chemical, and botanical products. The company is headquartered in Mumbai, Maharashtra. The company is primarily engaged in the development, manufacturing, and marketing of finished dosages. The Company’s products include parenteral solutions, effervescent, nutritional products, and medical device. Its products categories include urinary alkalizer, cephalosporins products, gastroenterology, non steroidal anti-inflammatory drugs (NSAIDs), anticonvulsant/antiepileptic, adrenergic agonist, neurotonic, muscle relaxant/stimulant, aminoglycosides, anti-infective, anti-inflammatory, anti-malarials, anti-hypertensive, anaesthetic, uterine stimulants. Its parenteral solutions include neurotonic, veterinary products, metered nasal drops, vaccines, oncology, and ophthalmic products. Its effervescent products include Roipar, Duregra, And Roivit. The firm offers nutritional products, such as Celtine. The firm also offers medical devices, such as C-Seal.

KILITCH Intrinsic Value
251.63 INR
Overvaluation 22%
Intrinsic Value
Price
K

See Also

What is Kilitch Drugs (India) Ltd's EPS (Diluted)?
EPS (Diluted)
10.2 INR

Based on the financial report for Sep 30, 2024, Kilitch Drugs (India) Ltd's EPS (Diluted) amounts to 10.2 INR.

What is Kilitch Drugs (India) Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
36%

Over the last year, the EPS (Diluted) growth was 18%. The average annual EPS (Diluted) growth rates for Kilitch Drugs (India) Ltd have been 36% over the past three years .

Back to Top